Xcel Brands, Inc. quarterly report, Q2 FY2023

Xcel Brands, Inc. — Q2 2023 Form 10-Q

Reporting period: Three and six months ended June 30, 2023. Unaudited consolidated financial statements. Xcel operates consumer brands through licensing, wholesale, e-commerce and other retail channels. During 2023 it substantially completed a shift from a wholesale/licensing hybrid model to a “licensing-plus” model, relying more on partners to operate product businesses.

Financial performance and position

MetricQ2 2023Q2 2022First half 2023First half 2022
Net revenue$6.8m$8.5m$12.8m$17.2m
Net licensing revenue$2.4m$5.2m$4.7m$11.1m
Net sales$4.4m$3.3m$8.2m$6.1m
Gross profit$3.0m$5.9m$6.3m$13.0m
Operating income (loss)$(3.7)m$15.2m$(9.6)m$12.1m
Net income (loss) attributable to Xcel shareholders$(3.5)m$9.5m$(9.1)m$6.0m
Operating cash flowNot separately presentedNot separately presented$(1.5)m$(8.7)m
Adjusted EBITDA, non-GAAP$(0.9)m$(2.8)m$(2.9)m$(3.7)m

Product gross margin (net sales less cost of goods sold, divided by net sales) was approximately 13% in Q2 and 21% in the first half, versus 22% and 30% in the comparable 2022 periods. The company attributed the decline to discounted apparel and jewelry inventory liquidation. Lower licensing revenue largely reflects the 2022 sale of a majority interest in the Isaac Mizrahi brand. The 2022 comparisons also include a $20.6m gain on that sale and a $2.3m debt-extinguishment loss.

At June 30, cash was $3.5m, down from $4.6m at year-end 2022; working capital, using the company’s stated adjusted definition, was $6.0m versus $8.8m. Total assets were $81.5m and stockholders’ equity was $60.6m. The company reported no debt. Operating lease liabilities totaled $5.9m. Cash decreased $1.1m in the first half; investing activities provided $0.4m and financing activities had no cash flow.

Material changes, outlook and risks

  • Restructuring and cost reduction: Management said the operating transition was substantially complete by June 30. It reported annualized payroll reductions of approximately $6m and operating expense reductions of approximately $7m versus the prior-year periods. Q2 direct operating expenses fell to $5.2m from $9.5m.
  • Licensing arrangements: New partner arrangements include Ripka licenses with Jewelry Television, C Wonder wholesale licensing with One Jeanswear Group, and a May 2023 Halston master license. The Halston contract includes an upfront payment and guaranteed royalties, has a 25-year term with termination opportunities at five-year intervals, and provides a $5m purchase option at the end of the term. Xcel granted a security interest in Halston trademarks and issued a warrant for up to 1m shares at $1.50, subject to royalty targets. The upfront payment and minimum royalties resulted in $4.89m of deferred revenue at quarter-end, to be recognized over 5.5 years.
  • Liquidity and management outlook: The company reported losses, an accumulated deficit of $41.9m and first-half operating cash outflow of $1.5m, which had raised substantial doubt about continued operations. Management said the new business model and cost reductions alleviate the going-concern uncertainty and expects adequate cash flows for operating and capital needs for at least 12 months after the filing date. No numerical revenue or earnings guidance was provided.
  • Concentration and market risks: Qurate agreements generated 26% of Q2 and first-half 2023 net revenue; Qurate receivables were 23% of accounts receivable at June 30. Management cited shipping disruptions, elevated input and logistics costs expected to persist through at least most of 2023, potential recession-related demand weakness, and dependence on licensees, retail partners and fashion trends.
  • Contingencies and unusual items: The Lori Goldstein earn-out liability was $6.4m at June 30 ($1.4m current and $5.0m long-term). The Isaac Mizrahi transaction includes a potential purchase-price adjustment; no liability was recorded, and management considered payment remote. Q2 also included a $0.44m gain from settling a former store lease, a $0.35m gain on sale of a limited-partner interest, and a $0.52m equity-method loss on the Isaac Mizrahi investment. Management said pending ordinary-course litigation was not expected to have a material adverse effect.

Important facts for investors to verify

  • Whether the licensing transition delivers recurring cash generation sufficient to offset continuing losses and limited cash reserves.
  • Actual performance and collectability under the Halston minimum royalty commitments, alongside the contract’s termination, purchase-option, security-interest and warrant terms.
  • Ongoing dependence on Qurate and the impact of further changes in Qurate sales or payments.
  • The remaining Lori Goldstein earn-out and any change in the likelihood or amount of the unrecorded Isaac Mizrahi contingent obligation.
  • Whether cost savings and inventory liquidation are sustainable without further pressure on product margins or brand demand.